摘要
肿瘤的生长转移与肿瘤血管生成密切相关,抗血管生成是治疗肿瘤的新策略。内皮抑素是特异性的血管内皮细胞生长抑制因子,能显著抑制肿瘤血管增生并诱导肿瘤细胞凋亡。内皮抑素的抗血管生成治疗和血管靶向基因治疗,为治疗肺癌提供了广阔前景。
The growth and metastasis of tumor are correlated with angiogenesis.Antiangiogenesis is a new tactic in treating tumor.Endostatin can specifically inhibit tumor endothelial cell proliferation,angiogenesis and induce cell apoptosis.The therapy of antiangiogenesis and target gene offer a broad clinic prospect for lung cancer.
出处
《药学与临床研究》
2007年第3期184-186,共3页
Pharmaceutical and Clinical Research
关键词
内皮抑素
血管生成
肺癌
Endostatin
Angiogenesis
Lung cancer